Hypertension after kidney transplant

American Journal of Kidney Diseases

Volumn 57, Issue 2, 2011, Pages 331-341

  Mangray, Mahendra ^a   Vella, John P ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

human; Hypertension; immunosuppression; kidney; transplantation

Indexed keywords

AMILORIDE; AMLODIPINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CANDESARTAN; CONTRAST MEDIUM; CYCLOSPORIN; DILTIAZEM; DOXAZOSIN; FUROSEMIDE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; IRBESARTAN; LISINOPRIL; LOSARTAN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METOPROLOL; MINOXIDIL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIFEDIPINE; NITRIC OXIDE; PREDNISONE; RAMIPRIL; RAPAMYCIN; SPIRONOLACTONE; STEROID; TACROLIMUS; VERAPAMIL;

ACUTE KIDNEY FAILURE; ACUTE VASCULAR REJECTION; ADULT; ANEMIA; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BRADYCARDIA; CASE REPORT; CREATININE BLOOD LEVEL; DRUG INDUCED HEADACHE; DRUG POTENTIATION; EDEMA; FATIGUE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART LEFT VENTRICLE HYPERTROPHY; HEMATOMA; HIRSUTISM; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOKALEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MALE; NEPHROTOXICITY; PLASMAPHERESIS; SODIUM RETENTION; STENT; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VASOCONSTRICTION; VASODILATATION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; TREATMENT OUTCOME;

EID: 78751664815     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.10.048     Document Type: Article

References (81)

1. J.P. Vella, and G.M. Danovitch Transplantation NephSAP J Am Soc Nephrol 7 1 2008 6 54
2. J.P. Vella, and G.M. Danovitch Transplantation NephSAP J Am Soc Nephrol 5 4 2006 201 274
3. US Renal Data System USRDS 2008 Annual Data Report 2008 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD http://www.usrds.org Accessed January 5, 2010
4. J.P. Vella, and D.J. Cohen Transplantation NephSAP J Am Soc Nephrol 8 6 2009 424 492
5. A.V. Chobanian, G.L. Bakris, and H.R. Black The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 19 2003 2560 2572
6. National Kidney Foundation K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease Am J Kidney Dis 43 5 suppl 1 2004 S1 S290
7. B.L. Kasiske, M.G. Zeier, and J.R. Chapman KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary Kidney Int 77 4 2010 299 311
8. EBPG Expert Group on Renal Transplantation European best practice guidelines for renal transplantation Section IV: long-term management of the transplant recipient Nephrol Dial Transplant 17 suppl 4 2002 1 67
9. W.C. Cushman, G.W. Evans, and R.P. Byington Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med 362 17 2010 1575 1585
10. S.L. Linas, P.D. Miller, and K.M. McDonald Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys N Engl J Med 298 26 1978 1440 1444
11. M.R. First, J.F. Neylan, L.L. Rocher, and A. Tejani Hypertension after renal transplantation J Am Soc Nephrol 4 8 suppl 1994 S30 S36
12. M.R. van der Schaaf, R.J. Hene, M. Floor, P.J. Blankestijn, and H.A. Koomans Hypertension after renal transplantation Calcium channel or converting enzyme blockade? Hypertension 25 1 1995 77 81
13. S.C. Textor, V.J. Canzanello, and S.J. Taler Cyclosporine-induced hypertension after transplantation Mayo Clin Proc 69 12 1994 1182 1193
14. E. Paoletti, M. Gherzi, M. Amidone, F. Massarino, and G. Cannella Association of arterial hypertension with renal target organ damage in kidney transplant recipients: the predictive role of ambulatory blood pressure monitoring Transplantation 87 12 2009 1864 1869
15. B.L. Kasiske, S. Anjum, and R. Shah Hypertension after kidney transplantation Am J Kidney Dis 43 6 2004 1071 1081
16. G. Opelz, T. Wujciak, and E. Ritz Association of chronic kidney graft failure with recipient blood pressure Collaborative Transplant Study Kidney Int 53 1 1998 217 222
17. G. Opelz, and B. Dohler Improved long-term outcomes after renal transplantation associated with blood pressure control Am J Transplant 5 11 2005 2725 2731
18. G.V. Prasad, M.M. Nash, and J.S. Zaltzman A prospective study of the physician effect on blood pressure in renal-transplant recipients Nephrol Dial Transplant 18 5 2003 996 1000
19. M.G. Myers, S.W. Tobe, D.W. McKay, P. Bolli, B.R. Hemmelgarn, and F.A. McAlister New algorithm for the diagnosis of hypertension Am J Hypertens 18 10 2005 1369 1374
20. G. Bobrie, G. Chatellier, and N. Genes Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients JAMA 291 11 2004 1342 1349
21. G.S. Stergiou, P.G. Kalogeropoulos, and N.M. Baibas Prognostic value of home blood pressure measurement Blood Press Monit 12 6 2007 391 392
22. A.E. Stenehjem, H. Gudmundsdottir, and I. Os Office blood pressure measurements overestimate blood pressure control in renal transplant patients Blood Press Monit 11 3 2006 125 133
23. A.A. Haydar, A. Covic, and S. Jayawardene Insights from ambulatory blood pressure monitoring: diagnosis of hypertension and diurnal blood pressure in renal transplant recipients Transplantation 77 6 2004 849 853
24. E. Guidi, D. Menghetti, S. Milani, G. Montagnino, P. Palazzi, and G. Bianchi Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families J Am Soc Nephrol 7 8 1996 1131 1138
25. E. Guidi, M.G. Cozzi, E. Minetti, and G. Bianchi Donor and recipient family histories of hypertension influence renal impairment and blood pressure during acute rejections J Am Soc Nephrol 9 11 1998 2102 2107
26. C. Rigatto, R. Foley, J. Jeffery, C. Negrijn, C. Tribula, and P. Parfrey Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia J Am Soc Nephrol 14 2 2003 462 468
27. K. Midtvedt, H. Ihlen, and A. Hartmann Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study Transplantation 72 1 2001 107 111
28. J.E. Goodwin, J. Zhang, and D.S. Geller A critical role for vascular smooth muscle in acute glucocorticoid-induced hypertension J Am Soc Nephrol 19 7 2008 1291 1299
29. D.L. Veenstra, J.H. Best, J. Hornberger, S.D. Sullivan, and D.E. Hricik Incidence and long-term cost of steroid-related side effects after renal transplantation Am J Kidney Dis 33 5 1999 829 839
30. D.E. Hricik, J. Lautman, M.R. Bartucci, E.J. Moir, J.T. Mayes, and J.A. Schulak Variable effects of steroid withdrawal on blood pressure reduction in cyclosporine-treated renal transplant recipients Transplantation 53 6 1992 1232 1235
31. F. Vincenti, F.P. Schena, S. Paraskevas, I.A. Hauser, R.G. Walker, and J. Grinyo A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients Am J Transplant 8 2 2008 307 316
32. R.G. Luke Pathophysiology and treatment of posttransplant hypertension J Am Soc Nephrol 2 2 suppl 1 1991 S37 S44
33. H. Hohage, D. Bruckner, M. Arlt, B. Buchholz, W. Zidek, and C. Spieker Influence of cyclosporine A and FK506 on 24 h blood pressure monitoring in kidney transplant recipients Clin Nephrol 45 5 1996 342 344
34. D.H. Van Buren, J.F. Burke, and R.M. Lewis Renal function in patients receiving long-term cyclosporine therapy J Am Soc Nephrol 4 8 suppl 1994 S17 S22
35. M. Sander, T. Lyson, G.D. Thomas, and R.G. Victor Sympathetic neural mechanisms of cyclosporine-induced hypertension Am J Hypertens 9 11 1996 121S 138S
36. N. Shiba, M.C. Chan, B.W. Kwok, H.A. Valantine, R.C. Robbins, and S.A. Hunt Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience J Heart Lung Transplant 23 2 2004 155 164
37. M. Pascual, J. Curtis, and F.L. Delmonico A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation Transplantation 75 9 2003 1501 1505
38. R. Margreiter Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study Lancet 359 9308 2002 741 746
39. T. Gonwa, R. Mendez, H.C. Yang, S. Weinstein, S. Jensik, and S. Steinberg Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months Transplantation 75 8 2003 1213 1220
40. H.U. Meier-Kriesche, J.D. Schold, T.R. Srinivas, R.J. Howard, S. Fujita, and B. Kaplan Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus Am J Transplant 5 9 2005 2273 2280
41. V. Karthikeyan, J. Karpinski, R.C. Nair, and G. Knoll The burden of chronic kidney disease in renal transplant recipients Am J Transplant 4 2 2004 262 269
42. F.M. Modena, T.H. Hostetter, A.K. Salahudeen, J.S. Najarian, A.J. Matas, and M.E. Rosenberg Progression of kidney disease in chronic renal transplant rejection Transplantation 52 2 1991 239 244
43. B.L. Kasiske, S. Anjum, and R. Shah Hypertension after kidney transplantation Am J Kidney Dis 43 6 2004 1071 1081
44. M.M. Mitsnefes, P.R. Khoury, and P.T. McEnery Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients J Pediatr 143 1 2003 98 103
45. A.P. Monaco, J.F. Burke Jr, and R.M. Ferguson Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion Am J Kidney Dis 33 1 1999 150 160
46. U. Yakupoglu, E. Baranowska-Daca, D. Rosen, R. Barrios, W.N. Suki, and L.D. Truong Post-transplant nephrotic syndrome: a comprehensive clinicopathologic study Kidney Int 65 6 2004 2360 2370
47. K. Solez, R.B. Colvin, and L.C. Racusen Banff 05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN) Am J Transplant 7 3 2007 518 526
48. E.M. Briganti, G.R. Russ, J.J. McNeil, R.C. Atkins, and S.J. Chadban Risk of renal allograft loss from recurrent glomerulonephritis N Engl J Med 347 2 2002 103 109
49. S. Hariharan, V.R. Peddi, and V.J. Savin Recurrent and de novo renal diseases after renal transplantation: a report from the renal allograft disease registry Am J Kidney Dis 31 6 1998 928 931
50. D. Dragun, D.N. Muller, and J.H. Brasen Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection N Engl J Med 352 6 2005 558 569
51. S. Bruno, G. Remuzzi, and P. Ruggenenti Transplant renal artery stenosis J Am Soc Nephrol 15 1 2004 134 141
52. V. Audard, M. Matignon, and F. Hemery Risk factors and long-term outcome of transplant renal artery stenosis in adult recipients after treatment by percutaneous transluminal angioplasty Am J Transplant 6 1 2006 95 99
53. S. Pouria, O.I. State, W. Wong, and B.M. Hendry CMV infection is associated with transplant renal artery stenosis QJM 91 3 1998 185 189
54. A. Humar, and A.J. Matas Surgical complications after kidney transplantation Semin Dial 18 6 2005 505 510
55. B.R. Sankari, M. Geisinger, M. Zelch, B. Brouhard, R. Cunningham, and A.C. Novick Post-transplant renal artery stenosis: impact of therapy on long-term kidney function and blood pressure control J Urol 155 6 1996 1860 1864
56. D.E. Hricik, P.J. Browning, R. Kopelman, W.E. Goorno, N.E. Madias, and V.J. Dzau Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney N Engl J Med 308 7 1983 373 376
57. Ghazanfar A, Tavakoli A, Augustine T, Pararajasingam R, Riad H, Chalmers N. Management of transplant renal artery stenosis and its impact on long term allograft survival: a single centre experience [published online ahead of print July 2, 2010]. Nephrol Dial Transplant. doi:10.1093/ndt/gfq393.
58. W.C. ONeill, and D.A. Baumgarten Ultrasonography in renal transplantation Am J Kidney Dis 39 4 2002 663 678
59. J.C. Li, Z.G. Ji, S. Cai, Y.X. Jiang, Q. Dai, and J.X. Zhang Evaluation of severe transplant renal artery stenosis with Doppler sonography J Clin Ultrasound 33 6 2005 261 269
60. M.R. Rudnick, J.S. Berns, R.M. Cohen, and S. Goldfarb Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolisma critical review Am J Kidney Dis 24 4 1994 713 727
61. P. Loubeyre, R. Cahen, and F. Grozel Transplant renal artery stenosis Evaluation of diagnosis with magnetic resonance angiography compared with color duplex sonography and arteriography Transplantation 62 4 1996 446 450
62. N.H. Patel, R.M. Jindal, and T. Wilkin Renal arterial stenosis in renal allografts: retrospective study of predisposing factors and outcome after percutaneous transluminal angioplasty Radiology 219 3 2001 663 667
63. F.C. Fervenza, R.A. Lafayette, E.J. Alfrey, and J. Petersen Renal artery stenosis in kidney transplants Am J Kidney Dis 31 1 1998 142 148
64. A.H. Rike, G. Mogilishetty, and R.R. Alloway Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroids Clin Transplant 22 2 2008 229 235
65. J.D. Chan, T.D. Rea, and N.L. Smith Association of beta-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS) Am Heart J 150 3 2005 464 470
66. P. Ruggenenti, N. Perico, and L. Mosconi Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion Kidney Int 43 3 1993 706 711
67. K. Midtvedt, A. Hartmann, and A. Foss Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril Transplantation 72 11 2001 1787 1792
68. K. Midtvedt, and A. Hartmann Hypertension after kidney transplantation: are treatment guidelines emerging? Nephrol Dial Transplant 17 7 2002 1166 1169
69. T.A. McCulloch, S.J. Harper, and P.K. Donnelly Influence of nifedipine on interstitial fibrosis in renal transplant allografts treated with cyclosporin A J Clin Pathol 47 9 1994 839 842
70. S.D. Ladefoged, and C.B. Andersen Calcium channel blockers in kidney transplantation Clin Transplant 8 2 pt 1 1994 128 133
71. G. Mourad, J. Ribstein, and A. Mimran Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants Kidney Int 43 2 1993 419 425
72. J.M. Kovarik, D. Beyer, M.N. Bizot, Q. Jiang, M.J. Allison, and R.L. Schmouder Pharmacokinetic interaction between verapamil and everolimus in healthy subjects Br J Clin Pharmacol 60 4 2005 434 437
73. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) Lancet 349 9069 1997 1857 1863
74. E.J. Lewis, L.G. Hunsicker, R.P. Bain, and R.D. Rohde The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy The Collaborative Study Group N Engl J Med 329 20 1993 1456 1462
75. G. Maschio, D. Alberti, and G. Janin Effect of the angiotensin- converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group N Engl J Med 334 15 1996 939 945
76. P. Ruggenenti, A. Perna, G. Gherardi, F. Gaspari, R. Benini, and G. Remuzzi Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy Lancet 352 9136 1998 1252 1256
77. J.J. Curtis, D.A. Laskow, P.A. Jones, B.A. Julian, R.S. Gaston, and R.G. Luke Captopril-induced fall in glomerular filtration rate in cyclosporine-treated hypertensive patients J Am Soc Nephrol 3 9 1993 1570 1574
78. D.V. Vlahakos, V.J. Canzanello, M.P. Madaio, and N.E. Madias Enalapril-associated anemia in renal transplant recipients treated for hypertension Am J Kidney Dis 17 2 1991 199 205
79. R.S. Gaston, B.A. Julian, and J.J. Curtis Posttransplant erythrocytosis: an enigma revisited Am J Kidney Dis 24 1 1994 1 11
80. S. Hiremath, D. Fergusson, S. Doucette, A.V. Mulay, and G.A. Knoll Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence Am J Transplant 7 10 2007 2350 2360
81. L.A. Fleisher, J.A. Beckman, and K.A. Brown ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery J Am Coll Cardiol 50 17 2007 1707 1732